Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Single-molecule profiling of full-length Tau isoforms and phosphorylated proteoforms

SPoTIP

Abnormal post-translational modifications (PTMs) can lead to the aggregation of Tau proteins, which characterize a wide range of neurodegenerative diseases known as tauopathies. Some abnormal Tau proteins will be released into biological fluids, providing a chance for minimally- or non-invasive diagnosis. For Alzheimer's Disease (AD), site-specific...

Funding Programme
Start Date
End Date
Total Funding
€ 260 347
European Countries Involved

siRNA-based therapy for cerebral tauopathies

SITAU

Neurodegenerative disorders are an increasing healthcare problem. Many of these diseases are characterized by aggregation of proteins, which leads to neuronal dysregulation and cell death. Neurofibrillary tangles, pathological aggregates of tau protein, are the characteristic neuropathological stigmata defining a group of disorders termed...

Funding Programme
Start Date
End Date
Total Funding
€ 158 695
European Countries Involved

Sleep and episodic memory consolidation: ‘No-report’ paradigms, brain mechanisms, and dementia

SleepEpisMemory

Episodic memory is a core element of the human mind, but how experiencing an episode consolidates into long-term memory remains a central unsolved question in cognitive science. We will test the hypothesis that hippocampal-cortical dialogue (HCD) during sleep promotes memory consolidation, a hypothesis that has been largely beyond direct testing in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 745 000
European Countries Involved

Sleep genes and Circadian rhythm in dementia prevention

CLOCKED

Changes in sleep patterns are common among people with dementia, however why short (≤6hrs) or long sleep (≥9hrs) duration is less favorable for dementia, remains unknown. Given that approximately 46% & 44% of variability in sleep duration is explained by genetics, it is pertinent to consider genetic influences when understanding the mechanisms...

Funding Programme
Start Date
End Date
Total Funding
€ 206 887
European Countries Involved

Small molecule stabilizers of 14-3-3 Protein-Protein Interactions as novel drugs in cancer and neurodegenerative diseases

14-3-3Stabs

The objective of the application is the development and characterization of small molecule stabilizers of protein-protein interactions (“Molecular Glues”) as a novel class of biological tool compounds and potential therapeutic drugs for the treatment of cancer as well as Alzheimer’s and Parkinson’s Disease, respectively. As biological targets we...

Funding Programme
Start Date
End Date
Total Funding
€ 2 008 622
European Countries Involved

Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia

SVDs-at-target

Stroke and dementia rank among the most pressing health issues in Europe. Cerebral small vessel diseases (SVDs) have emerged as a central link between these two major co-morbidities. SVDs account for more than 30% of strokes and at least 40% of dementia cases. They encounter multiple distinct diseases that can be separated based on their underlying...

Funding Programme
Start Date
End Date
Total Funding
€ 5 998 300
European Countries Involved

Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C

NanoMop

Niemann-Pick Disease Type C (NPC), also known as “childhood Alzheimer’s”, is a rare genetic disorder caused by the accumulation of cholesterol particularly in the brain with subsequent cognitive and mobility decline. In the EU NPC has an incidence of 1 per 100,000 people. Most cases are detected during childhood and progress to cause life...

Funding Programme
Start Date
End Date
Total Funding
€ 145 846
European Countries Involved

Smart HOme for the elderly PEople

HOPE

The Hope” solution consists of an integrated, smart platform that enables the elderly people with Alzheimer’s disease to use innovative technology for a more independent life, easy access to information, monitor their health, which provides a basis for integrating services for the elderly population while they are at home.  HOPE is a self-operated...

Funding Programme
Start Date
End Date
Total Funding
€ 2 138 094
European Countries Involved

Social Interactive Care System  to support the well-being of people living with dementia (Many-Me)

Many-Me

The main objective of Many-Me is to offer patients in different stages of dementia a friendly and enjoyable environment supported by ICT solutions, empowering them to self-manage their condition by engaging and learning from people in a similar situation, make friends and attend support groups, test and adopt routines or techniques that help memory...

Funding Programme
Start Date
End Date
Total Funding
€ 2 400 000
European Countries Involved

Social Health And Reserve in the Dementia patient journey

SHARED

The role of social health in onset, disease course and prognosis of dementia remains underexplored. Social health has been conceptualized as the influence of social resources in finding a balance between capacities and limitations. Moreover, social health affects and is affected by biological processes that underlie the dementia syndrome. This...

Funding Programme
Start Date
End Date
European Countries Involved

Space coding in hippocampo-entorhinal neuronal assemblies

SPACEBRAIN

Despite impressive advances in almost every field of neuroscience, our insights into brain function remain largely confined to its building blocks at the microscopic level, and to phenomenological descriptions at the macroscopic level. Understanding how complex mental functions originate from electrical and chemical processes in brain cells...

Funding Programme
Start Date
End Date
Total Funding
€ 7 996 767
European Countries Involved

Stability and dynamics at different spatial scales: From physiology to Alzheimer's degeneration

MacroStability

How neuronal circuits maintain the balance between stability and plasticity in a constantly changing environment remains one of the most fundamental questions in neuroscience. Empirical and theoretical studies suggest that homeostatic negative feedback mechanisms operate to stabilize the function of a system at a set point level of activity. While...

Funding Programme
Start Date
End Date
Total Funding
€ 2 000 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).